Irritable bowel syndrome: a review and update.

Published on Mar 1, 2012in Clinics in Colon and Rectal Surgery1.798
· DOI :10.1055/S-0032-1301759
Kaitlin Occhipinti1
Estimated H-index: 1
James W. Smith1
Estimated H-index: 1
The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with scientific advancement. IBS is a common functional bowel disorder that generates a significant health care burden and is the most commonly diagnosed gastrointestinal condition. There are well-established diagnostic criteria and algorithms for the initial evaluation of patients presenting with the symptoms of IBS. The symptoms can be targeted for therapy with a variety of pharmaceutical and nonpharmaceutical agents. Therapy should be individualized for the patient, and the cornerstone for any effective treatment strategy should be the solid patient–physician relationship.
📖 Papers frequently viewed together
3,943 Citations
1 Citations
9 Citations
#1Susan Gaylord (UNC: University of North Carolina at Chapel Hill)H-Index: 26
#2Olafur S. Palsson (UNC: University of North Carolina at Chapel Hill)H-Index: 50
Last. William E. Whitehead (UNC: University of North Carolina at Chapel Hill)H-Index: 102
view all 9 authors...
Mindfulness Training Reduces the Severity of Irritable Bowel Syndrome in Women: Results of a Randomized Controlled Trial
184 CitationsSource
#1Jessica R Biesiekierski (Box Hill Hospital)H-Index: 14
#2Evan NewnhamH-Index: 13
Last. Peter R. GibsonH-Index: 86
view all 9 authors...
Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial
548 CitationsSource
#1Mark Pimentel (Cedars-Sinai Medical Center)H-Index: 61
#2Anthony Lembo (Harvard University)H-Index: 71
Last. William P. Forbes (Salix Pharmaceuticals)H-Index: 28
view all 10 authors...
Background Evidence suggests that gut flora may play an important role in the pathophysiology of the irritable bowel syndrome (IBS). We evaluated rifaximin, a minimally absorbed antibiotic, as treatment for IBS. Methods In two identically designed, phase 3, double-blind, placebo-controlled trials (TARGET 1 and TARGET 2), patients who had IBS without constipation were randomly assigned to either rifaximin at a dose of 550 mg or placebo, three times daily for 2 weeks, and were followed for an addi...
713 CitationsSource
#1Derrick K Ong (Monash University)H-Index: 2
#2Shaylyn B Mitchell (Monash University)H-Index: 2
Last. Jane G. Muir (Monash University)H-Index: 42
view all 9 authors...
Background and Aim: Reduction of short-chain poorly absorbed carbohydrates (FODMAPs) in the diet reduces symptoms of irritable bowel syndrome (IBS). In the present study, we aimed to compare the patterns of breath hydrogen and methane and symptoms produced in response to diets that differed only in FODMAP content. Methods: Fifteen healthy subjects and 15 with IBS (Rome III criteria) undertook a single-blind, crossover intervention trial involving consuming provided diets that were either low (9 ...
415 CitationsSource
#1Shahin Merat (Tehran University of Medical Sciences)H-Index: 45
#2Shadi Khalili (Tehran University of Medical Sciences)H-Index: 1
Last. Reza Malekzadeh (Tehran University of Medical Sciences)H-Index: 127
view all 6 authors...
Herbal remedies, particularly peppermint, have been reported to be helpful in controlling symptoms of irritable bowel syndrome (IBS). We conducted a randomized double-blind placebo-controlled study on 90 outpatients with IBS. Subjects took one capsule of enteric-coated, delayed-release peppermint oil (Colpermin) or placebo three times daily for 8 weeks. We visited patients after the first, fourth, and eighth weeks and evaluated their symptoms and quality of life. The number of subjects free from...
99 CitationsSource
#1C.J. Bijkerk (UU: Utrecht University)H-Index: 4
#2N.J. de WitH-Index: 21
Last. Arno W. HoesH-Index: 103
view all 6 authors...
Objective To determine the effectiveness of increasing the dietary content of soluble fibre (psyllium) or insoluble fibre (bran) in patients with irritable bowel syndrome. Design Randomised controlled trial. Setting General practice. Participants 275 patients aged 18-65 years with irritable bowel syndrome. Interventions 12 weeks of treatment with 10 g psyllium (n=85), 10 g bran (n=97), or 10 g placebo (rice flour) (n=93). Main outcome measures The primary end point was adequate symptom relief du...
221 CitationsSource
#1Alexander C. Ford (MUMC: McMaster University Medical Centre)H-Index: 86
#2Nicholas J. Talley (Mayo Clinic)H-Index: 183
Last. Paul Moayyedi (McMaster University)H-Index: 115
view all 5 authors...
Objective: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence for treatment of the condition with antidepressants and psychological therapies is conflicting. Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to May 2008). Setting: RCTs based in primary, secondary, and tertiary care. Patients: Adults with IBS. Interventions: Antidepressants versu...
482 CitationsSource
#5Charles Scott (Sucampo Pharmaceuticals)H-Index: 6
#6Raymond M. Panas (Sucampo Pharmaceuticals)H-Index: 7
Summary Background Effective treatments for irritable bowel syndrome with constipation (IBS-C) are lacking. Aim To assess the efficacy and safety of lubiprostone in IBS-C. Methods A combined analysis was performed among 1171 patients with a Rome II diagnosis of IBS-C in two phase-3 randomized trials of lubiprostone 8 mcg vs. placebo twice daily for 12 weeks. Using a balanced seven-point Likert scale ranging from significantly relieved (+3), to significantly worse (−3), patients responded on thei...
291 CitationsSource
#1Lawrence J. Brandt (Yeshiva University)H-Index: 10
#2William D. Chey (UM: University of Michigan)H-Index: 78
Last. Paul Moayyedi (McMaster University)H-Index: 115
view all 9 authors...
544 CitationsSource
#1Darren M. Brenner (NU: Northwestern University)H-Index: 17
#2Matthew J Moeller (UM: University of Michigan)H-Index: 1
Last. Philip S. SchoenfeldH-Index: 27
view all 4 authors...
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
307 CitationsSource
Cited By44
#1He-yong Tang (Anhui University of Chinese Medicine)H-Index: 1
#2Ai-Juan Jiang (Anda: Anhui University)
Last. Guo-Ming Shen (Anda: Anhui University)H-Index: 3
view all 7 authors...
Aims null Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by impaired gut-brain interaction. Considering the paucity of evidence in the Indian setting, the current study was conducted to determine the sociodemographics, clinical profiles, management practices, and patients' perception among newly diagnosed patients with IBS. null Methods null This was a cross-sectional, single-visit, observational, non-interventional, epidemiological study conducted across ...
#2Bu Hayee (University of Cambridge)H-Index: 8
Last. Ana Rodriguez-MateosH-Index: 33
view all 3 authors...
(Poly)phenols (PPs) may have a therapeutic benefit in gastrointestinal (GI) disorders, such as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). The aim of this review is to summarise the evidence-base in this regard. Observational evidence does not give a clear indication that PP intake has a preventative role for IBD or IBS, while interventional studies suggest these compounds may confer symptomatic and health-related quality of life improvements in known patients. There are ...
1 CitationsSource
#1Alireza khalilianH-Index: 1
Last. Maryam Mehrpooya (Yahoo!)H-Index: 8
view all 5 authors...
Background Ample evidence indicates the efficacy of serotonin type 3 (5-HT3) receptor antagonists in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Mirtazapine is an atypical antidepressant with a well-known 5-HT3 receptor antagonist property. This study, therefore, was undertaken to investigate whether compared to placebo, mirtazapine would be efficacious and safe in the treatment of patients with IBS-D. Methods From November 2019 until July 2020, 67 patie...
3 CitationsSource
Last. Amber RizwanH-Index: 5
view all 8 authors...
Introduction Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal disorder. Risk factors include infective enteritis, female sex, antibiotic exposure, anxiety, and depression. The aim of this study is to find out the prevalence of IBS in healthy population and determine the characteristics of symptoms. Material and methods A cross-section study was conducted in the internal medicine unit of a tertiary care hospital in multiple cities of Pakistan. Eight hundred...
#1Diana Di Liberto (University of Palermo)H-Index: 18
#2Daniela Carlisi (University of Palermo)H-Index: 21
Last. Marianna Lauricella (University of Palermo)H-Index: 25
view all 8 authors...
A lifelong adherence to a gluten-free (GF) diet is currently the only treatment for Celiac disease (CD), an autoimmune disorder that arises after gluten ingestion in individuals who are genetically predisposed. The gluten intake exerts toxic effects through several pathways involving gut barrier integrity, intestinal microbiota composition and immune system stimulation. However, despite the great benefit of GF diet for CD patients, its use has been debated. Indeed, individuals who adopt this die...
5 CitationsSource
#1Bahra Radhaa Hamarashid (Fırat University)H-Index: 1
#2Semih Dalkilic (Fırat University)H-Index: 3
Last. Sevda Kirbağ (Fırat University)H-Index: 2
view all 5 authors...
Nowadays irritable bowel syndrome is one of the most common functional gastrointestinal disorders (FGIDs) with global prevalence. It’s described by a change in the habit of the bowel system. Pathophysiology of IBS is unclear, therefore; IBS becomes a specific subject for many researchers to investigate and discover some biomarkers associated with IBS. Symptoms are a confusion of abdominal pain and bloating which is demonstrated according to Rome criteria. In this mini-review, we conclude that IB...
#1Amber Hanif PallaH-Index: 4
view all 5 authors...
Background Gastrointestinal disorders are often poorly managed, especially in developing countries, where there are limited resources and therapeutic options. Despite the rich diversity of medicinal plants that offer effective treatment options with fewer side effects, studies that provide scientific verification are lacking. Maerua subcordata (Gilg) DeWolf is among the plants claimed to have wide traditional medicine, use, including as a remedy against gastrointestinal problems. Therefore, this...
#1Cem MeydanH-Index: 23
#2Ebrahim AfshinnekooH-Index: 18
Last. Joel T. DudleyH-Index: 61
view all 12 authors...
Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder worldwide, and the most common reason for referral to gastroenterology clinics. However, the pathophysiology is still not fully understood and consequently current management guidelines are very symptom-specific, leading to mixed results. Here we present a study of 88 individuals with IBS who had baseline sequencing of their gut microbiome (stool samples), received targeted interventions that included dieta...
4 CitationsSource
#1Erin D. LewisH-Index: 12
#2Joseph M. AntonyH-Index: 13
Last. Malkanthi EvansH-Index: 14
view all 7 authors...
Specific probiotic strains can alleviate the gastrointestinal (GI) symptoms and psychiatric comorbidities of irritable bowel syndrome (IBS). In this randomized, double-blind, placebo-controlled study, the efficacy of Lactobacillus paracasei HA-196 (L. paracasei) and Bifidobacterium longum R0175 (B. longum) in reducing the GI and psychological symptoms of IBS was evaluated in 251 adults with either constipation (IBS-C), diarrhea (IBS-D), or mixed-pattern (IBS-M). Following a 2-week run-in period,...
6 CitationsSource